Navigation Links
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
Date:8/6/2014

SEATTLE, Aug. 7, 2014 /PRNewswire/ --CTI BioPharma Corp. (CTI or the Company) (NASDAQ and MTA: CTIC) announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy. Pacritinib is an oral tyrosine kinase inhibitor with dual activity against JAK2 and FLT3. The drug candidate is currently being evaluated in two Phase 3 clinical trials, known as the PERSIST program, for patients with myelofibrosis.

"We are very pleased that the pacritinib development program in myelofibrosis has been granted Fast Track designation, and we look forward to continuing to work closely with the FDA on this important drug candidate," stated James A. Bianco, M.D., President and CEO. "We believe that pacritinib's unique profile has the potential to serve an unmet medical need that currently exists in this patient population, particularly for those patients with disease or therapy-related low platelet counts."

The Fast Track process is designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need. An unmet need is a condition whose treatment or diagnosis is not addressed adequately by available therapy. The purpose of the Fast Track designation is to make important new drugs available to the patient earlier. The Fast Track program also enables a company to submit sections of the NDA on a rolling basis as data becomes available. This enables the FDA to review sections of the NDA as they are received, rather than waiting until every section of the application is completed before the enti
'/>"/>

SOURCE CTI BioPharma
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2. US Patent Office Grants McCord Research Endothelial Cell Treatment Patent
3. FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Candidiasis
4. FDA Grants Orphan Drug Designation to Omeros OMS721 for Complement-Mediated Thrombotic Microangiopathies
5. FDA Grants Approval of IND to Commence a Phase 3 Pivotal Study for ST10 for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease
6. Auxilium Pharmaceuticals, Inc. Announces Court Grants Upsher-Smith Laboratories Motion For Summary Judgment
7. FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Aspergillosis
8. RadSite Grants Accreditation to First Wave of MIPPA Program Applicants
9. NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement
10. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
11. FDA Grants 510(k) Clearance for Innovative Fuse Gastroscope from EndoChoice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Five MinuteClinic walk-in medical clinics ... metropolitan area. Three clinics opened in Memphis ... A fourth clinic will be added in Springfield ... Bartlett is expected to open October 22.  MinuteClinic is ... the United States . The ...
(Date:9/19/2014)...  Lpath, Inc. (NASDAQ: LPTN ), ... today that it has entered into definitive agreements ... and 3,605,042 unregistered warrants in a registered direct ... share of common stock and one unregistered warrant ... will be $3.475.  The warrants have an exercise ...
(Date:9/19/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... ITCA 650 (continuous subcutaneous delivery of exenatide) in type ... the 50 th Annual Meeting of the European ... the open-label, phase 3 FREEDOM-HBL (high baseline) trial showed ... poorly controlled type 2 diabetes. The results were presented ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... 26, 2007 - A new study published ... ("A National Survey of,Physician-Industry Relationships") on the ... the need for,profession-wide and public policy reforms ... that the existing,voluntary PhRMA (Pharmaceutical Research and ...
... 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced today ... of the Journal of Neuroscience a study,by ... National Jewish,Medical and Research Center demonstrating that ... 11207, demonstrated,neuroprotection in an animal model of ...
Cached Medicine Technology:Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3
(Date:9/20/2014)... Atlanta, GA (PRWEB) September 20, 2014 ... September 20, 2014. The first poster looked at the ... per cardiac cycle for calculating diastolic function. In conjunction ... with end-stage renal disease and normal LVEF by echo ... high-dose stress protocol, and standard SPECT. Emory Toolbox ...
(Date:9/20/2014)... September 21, 2014 Increases in ... to greater waste treatment volumes. However, government regulations ... waste from landfill. According to IBISWorld industry analyst ... implemented strategies aimed at reducing the volume of ... recycled and recovered.” Still, a large proportion of ...
(Date:9/20/2014)... Linda, CA (PRWEB) September 20, 2014 ... will receive a $250,000 pediatric cancer research grant from ... at Loma Linda University Children’s Hospital located on 11234 ... the work of Dr. Kimberley Payne, Associate Professor at ... Payne’s work focuses on leukemia in children. ...
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog ... life insurance plan provides for vulnerable family members. ... be a top priority for every provider. It is ... medical examinations and visiting a doctor. , Life ... provide coverage up to $300,000, but only to healthy ...
(Date:9/20/2014)... 2014 The festival season is coming soon. ... newly released luxurious cocktail dresses . A lot of ... decided to launch a new promotion for its high quality ... a discounted price, from 20 to 71 percent off. ... of choices. They are provided in many fashionable colors. Mary, ...
Breaking Medicine News(10 mins):Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2
... body fat for those at risk of insulin resistance , , ... slows the onset of early puberty and reduces the risk ... a Spanish study concludes. , "The findings indicate that ... puberty is faster in girls, the appearance of menses occurs ...
... Company reported in its,PULSE research publication that Blue Cross ... as revenues increased by 7.4% in 2007.,Insured membership decreased ... mean increase of 6.0%., Operating margins declined by ... 39 plans varied; 6 had improvements in operating margins ...
... escalates as state continues to reject appeal for,health insurance ... "The change we need recognizes health as a public ... count on and afford.", - Deval Patrick, 2008 ... ), BOSTON, June 17 The following was ...
... 17 Across industry sectors,sales drive profits. And ... and time management practices,according to benchmarking research from ... study shows the client still remains king for ... of their time,building solutions for clients and 25 ...
... bones don,t heal as they should, experts note , , TUESDAY, ... help improve healing of fractures, a finding that may lead ... of people whose broken bones fail to mend, say researchers ... Adult stems cells are specialized cells that can regenerate damaged ...
... of the connection, study says , , TUESDAY, June 17 ... apparently cuts both ways: Not only are people with ... developing depression, individuals with depression are also at risk ... both doctors and patients need to be more aware ...
Cached Medicine News:Health News:Diabetes Drug May Prevent Early Puberty in Young Girls 2Health News:Home Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval Patrick 2Health News:Home Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval Patrick 3Health News:High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance 2Health News:Stem Cells Might Treat Tough Fractures 2Health News:Diabetes and Depression Go Hand-in-Hand 2Health News:Diabetes and Depression Go Hand-in-Hand 3
... The advanced performance benefits of TiMAX™ ... generation of implants. DePuy ACEs Large Fragment ... biocompatibility and enhanced imaging compatibility over traditional ... unique thread design in the TiMAX bone ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... Fragment System has been conceived and engineered ... and user-friendly instrumentation. The modular system of ... instrumentation is designed to provide the surgeon ... and classic techniques of open reduction and ...
Medicine Products: